Showing results (1-10 of 112) with videos related to
Sort By:
Pageof 12
Pharmacological Research|August 12, 2019
The new entries in the therapeutic armamentarium: The small molecule JAK inhibitorsKatie Bechman, Mark Yates, James B GallowayThe Journal of Rheumatology|May 3, 2019
Placebo Response in Rheumatoid Arthritis Clinical TrialsKatie Bechman, Mark Yates, Sam Norton, et al.The Journal of Rheumatology|March 17, 2018
A Systematic Review and Metaanalysis of Antirheumatic Drugs and Vaccine Immunogenicity in Rheumatoid ArthritisSujith Subesinghe, Katie Bechman, Andrew I Rutherford, et al.BMC Rheumatology|December 9, 2020
A systematic review of CXCL13 as a biomarker of disease and treatment response in rheumatoid arthritisKatie Bechman, Anthony Dalrymple, Charles Southey-Bassols, et al.Expert Review of Clinical Immunology|December 3, 2021
The infection risks of JAK inhibitionMaryam A Adas, Edward Alveyn, Emma Cook, et al.Rheumatology (Oxford, England)|January 31, 2020
Is background methotrexate advantageous in extending TNF inhibitor drug survival in elderly patients with rheumatoid arthritis? An analysis of the British Society for Rheumatology Biologics RegisterKatie Bechman, Anuoluwapo Oke, Mark Yates, et al.The Journal of Rheumatology|September 17, 2019
Rising Incidence of Acute Hospital Admissions due to GoutMark D Russell, Mark Yates, Katie Bechman, et al.Arthritis Research & Therapy|April 19, 2020
Data quality predicts care quality: findings from a national clinical auditMark Yates, Katie Bechman, Elaine M Dennison, et al.Arthritis & Rheumatology (Hoboken, N.J.)|April 12, 2021
Nonserious Infections in Patients With Rheumatoid Arthritis: Results From the British Society for Rheumatology Biologics Register for Rheumatoid ArthritisKatie Bechman, Kapil Halai, Mark Yates, et al.Rheumatology (Oxford, England)|December 6, 2019
Variation and implications of treatment decisions in early rheumatoid arthritis: results from a nationwide cohort studyMark Yates, Alexander J MacGregor, Jo Ledingham, et al.Pageof 12